Consumer data and behavioral shifts in the US market The United States, where these drugs went mainstream first, provides a roadmap for this shift
It's not because these medications directly affect muscle tissue
10.1089/ars.2017.7230 3
Semaglutide base does not usually need dose adjustment in hepatic impairment, but treatment should still continue only under a doctor's supervision
Key TakeawaysPoison control calls linked to GLP-1 drugs have risen sharplySemaglutide is named in most reported casesMost incidents are due to accidental dosing errors.THURSDAY, June 25, 2026 (HealthDay News) As the use of GLP-1 medications for weight loss surges, so do calls to U.S
Recent Performance Masks Long-Term Underperformance FHLC has delivered strong short-term results, gaining 5.3% over the past month and 17.9% over the past year, outpacing the S&P 500 in both periods